In recent years, immunotherapy, especially represented by PD-1 inhibitors, has achieved significant advancement, and in certain cancers, immunotherapy has outperformed traditional chemotherapy and targeted therapy (8, 25, 26). The gene discussed is PDCD1; the disease is cancer.